Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Carcinogenesis
|
February 1, 1988
Specific binding proteins for selenium in rat tissues
B P Sani, J L Woodard, M C Pierson, et al.
Matrix (Stuttgart, Germany). Supplement
|
January 1, 1992
Degradation of collagen fibrils by live cells: role of expression and activation of procollagenase
H Birkedal-Hansen, H Y Lin, B Birkedal-Hansen, et al.
The Journal of Biological Chemistry
|
September 5, 1993
Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes
J G Lyons, B Birkedal-Hansen, M C Pierson, et al.
Matrix (Stuttgart, Germany). Supplement
|
January 1, 1992
Strategies for production of inhibitory monoclonal antibodies against matrix-degrading proteinases
B Birkedal-Hansen, J G Lyons, L J Windsor, et al.
Clinical and Experimental Rheumatology
|
January 1, 1997
Persistent expression of a soluble form of Fas/APO1 in continuously activated T cells from a patient with SLE
B Kovacs, T Szentendrei, J M Bednarek, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Carcinogenesis
|
February 1, 1988
Specific binding proteins for selenium in rat tissues
B P Sani, J L Woodard, M C Pierson, et al.
Matrix (Stuttgart, Germany). Supplement
|
January 1, 1992
Degradation of collagen fibrils by live cells: role of expression and activation of procollagenase
H Birkedal-Hansen, H Y Lin, B Birkedal-Hansen, et al.
The Journal of Biological Chemistry
|
September 5, 1993
Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes
J G Lyons, B Birkedal-Hansen, M C Pierson, et al.
Matrix (Stuttgart, Germany). Supplement
|
January 1, 1992
Strategies for production of inhibitory monoclonal antibodies against matrix-degrading proteinases
B Birkedal-Hansen, J G Lyons, L J Windsor, et al.
Clinical and Experimental Rheumatology
|
January 1, 1997
Persistent expression of a soluble form of Fas/APO1 in continuously activated T cells from a patient with SLE
B Kovacs, T Szentendrei, J M Bednarek, et al.
Page
of 1